Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
KORU Medical Systems Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
KRMD
Nasdaq
3841
https://www.korumedical.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for KORU Medical Systems Inc
KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference
- Mar 18th, 2024 9:24 pm
KORU Medical Systems Full Year 2023 Earnings: EPS Misses Expectations
- Mar 15th, 2024 10:58 am
KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance
- Mar 13th, 2024 8:05 pm
KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic
- Mar 11th, 2024 8:05 pm
KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin
- Mar 6th, 2024 12:00 pm
KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024
- Feb 21st, 2024 12:00 pm
Retail investors account for 39% of KORU Medical Systems, Inc.'s (NASDAQ:KRMD) ownership, while institutions account for 32%
- Feb 16th, 2024 10:43 am
KORU Medical Systems to Participate in Piper Sandler’s 35th Annual Healthcare Conference
- Nov 29th, 2023 12:00 pm
KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023
- Nov 28th, 2023 1:00 pm
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript
- Nov 9th, 2023 3:04 pm
The past three years for KORU Medical Systems (NASDAQ:KRMD) investors has not been profitable
- Nov 9th, 2023 11:16 am
KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook
- Nov 8th, 2023 11:11 pm
KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System
- Nov 8th, 2023 9:10 pm
KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer
- Nov 8th, 2023 9:08 pm
KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook
- Nov 8th, 2023 9:05 pm
KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60® Infusion System With Hizentra® 50 ML Prefilled Syringes
- Nov 7th, 2023 9:05 pm
KORU Medical Systems to Participate in Upcoming Investor Conferences
- Nov 2nd, 2023 8:05 pm
KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023
- Oct 25th, 2023 8:05 pm
KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference
- Oct 5th, 2023 11:05 am
KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors
- Oct 4th, 2023 8:05 pm
Scroll